BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:MGC028 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of MGC028\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06723236-2621@assetmemo.bio
DTSTAMP:20261121T005321Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:MGC028: Phase 1 readout est. (NCT06723236)
DESCRIPTION:MGC028\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Study 
 of MGC028 in Participants With Advanced Solid Tumors\nEstimated primary co
 mpletion: November 2026. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/mgc028#upcoming-events\nRegistry record: https://clinicaltrials.gov/st
 udy/NCT06723236
URL:https://assetmemo.bio/drug/mgc028#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
